Internal Medicine, Endocrinology, Diabetes, & Metabolism · Grosse Pointe, MI
NPI
1386859148
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
22201 Moross Rd, Suite 252
Grosse Pointe, MI, 48236
Phone (313) 343-4411
Groups this clinician bills Medicare through
Medicare paid, 2024
$62K
3,252 services
Medicare patients, 2024
305
Average age 72
Drug cost, 2024
$1.9M
3,764 prescriptions
Company payments, 2025
$24K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sherilyn J Russell was code 99214 (office e&m - established), 437 times for 259 patients. In total Sherilyn J Russell billed 3,252 services in 12 codes, and Medicare paid $62K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-12-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 437 | 259 | $89.52 | $39K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 329 | 220 | $12.70 | $4,179 |
| 82962 Clinical Chemistry | Office | 212 | 99 | $3.11 | $660 |
| 83036 Blood Count | Office | 135 | 84 | $9.14 | $1,234 |
| 95251 Test - Miscellaneous | Office | 120 | 53 | $25.25 | $3,030 |
| 99215 Office E&M - Established | Office | 53 | 42 | $116.19 | $6,158 |
| 99204 Office E&M - New | Office | 42 | 42 | $118.93 | $4,995 |
| 99205 Office E&M - New | Office | 14 | 14 | $132.59 | $1,856 |
By year: 2022 $57K for 4,484 services; 2023 $57K for 2,419 services; 2024 $62K for 3,252 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 212 | 99 | $3.11 | $660 |
| 83036 Blood Count | 135 | 84 | $9.14 | $1,234 |
Medicare prescription drug claims, 2024
In 2024, the drug Sherilyn J Russell prescribed most often to Medicare patients was Levothyroxine Sodium, with 804 prescriptions and refills. In total Sherilyn J Russell wrote 3,764 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 804 | 2,168 | 222 | $10K |
| Ozempic Semaglutide | 345 | 715 | 86 | $643K |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 202 | 501 | 73 | $25K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 200 | 602 | 75 | $36K |
| Metformin Hcl Generic | 197 | 523 | 58 | $2,543 |
| Metformin Hcl Er Metformin Hcl | 148 | 423 | 54 | $2,559 |
| Novolog Flexpen Insulin Aspart | 146 | 356 | 62 | $58K |
| Mounjaro Tirzepatide | 109 | 167 | 21 | $173K |
| Tresiba Flextouch U-100 Insulin Degludec | 108 | 296 | 39 | $104K |
| Trulicity Dulaglutide | 100 | 172 | 25 | $164K |
| Jardiance Empagliflozin | 87 | 219 | 31 | $120K |
| Humalog Kwikpen U-100 Insulin Lispro | 87 | 248 | 36 | $42K |
| Synthroid Levothyroxine Sodium | 83 | 239 | 30 | $8,081 |
| Alendronate Sodium Generic | 70 | 168 | 21 | $943 |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 64 | 178 | 20 | $51K |
Brand drugs: 2,060 claims; generic drugs: 1,319 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sherilyn J Russell $24K ($24K in general payments such as food, travel and fees) from 19 companies. The largest payer was Amgen Inc. with $23K.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 34 | $23K |
| Abbott Laboratories ABT | 13 | $194 |
| Medtronic, Inc. MDT | 4 | $69.99 |
| Novo Nordisk Inc NVO | 3 | $63.13 |
| Amneal Pharmaceuticals LLC AMRX | 3 | $53.38 |
| Ascensia Diabetes Care Us Inc. | 2 | $45.28 |
| Mannkind Corporation MNKD | 1 | $42.5 |
| Radius Health, Inc. | 2 | $41.7 |
| Amphastar Pharmaceuticals, Inc. AMPH | 2 | $35.89 |
| Soleno Therapeutics, Inc. SLNO | 1 | $28.93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.